To determine whether USMB treatment triggered AMPK activation, we probed for phosphorylation of AMPK (pT172-AMPK) and acetyl CoA-carboxylase (pS79-ACC), a substrate of AMPK, in three triple negative breast cancer cell models. This evidence concerns the gene PRKAA1 and triple-negative breast carcinoma.